Monthly Archives:

EBRT and Long-Term ADT Yields Good Results in Older High-Risk Prostate Cancer Patients

Quebec City—Noting that surgery is increasingly being used in high-risk prostate cancer patients, clinicians at the Center Hospital at the University of Montreal recently conducted a data analysis to help determine the best treatment modality for this patient population. The analysis utilized data in high-risk prostate cancer patients treated with external beam radiation (EBRT) and androgen deprivation therapy (ADT) at ... Read More »

Overall Survival Improved with Radium-223 and Concomitant Abiraterone

Quebec City—In the ALSYMPCA trial, patients with bone-symptomatic metastatic castration-resistant prostate cancer who were treated with radium-223 had improved overall survival compared with placebo (median, 14.9 months vs 11.6 months, hazard ratio=0.70). At the 67th Annual Meeting of the Northeastern Section of the American Urological Association, Fred Saad, MD, FRCSC, presented data from 696 early access program patients who were ... Read More »